当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Hereditary Cancer in Clinical Practice杂志
Hereditary Cancer in Clinical Practice
基本信息
期刊名称 Hereditary Cancer in Clinical Practice
HERED CANCER CLIN PR
期刊ISSN 1731-2302
期刊官方网站 http://hccpjournal.biomedcentral.com/
是否OA
出版商 BioMed Central Ltd.
出版周期 Quarterly
始发年份 2003
年文章数 16
最新影响因子 1.7(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 ONCOLOGY 肿瘤学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.05 0.843 0.791
Medicine
Genetics(clinical)
55 / 91 40%
Medicine
Oncology
178 / 321 44%
补充信息
自引率 4.10%
H-index 16
SCI收录状况 Science Citation Index Expanded
官方审稿时间
Speed
79 days to first decision for reviewed manuscripts only
57 days to first decision for all manuscripts 
140 days from submission to acceptance
13 days from acceptance to publication
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1731-2302%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/hccp/default.aspx
收稿范围

Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a discussion forum for the development appropriate healthcare strategies.

Cancergenetics encompasses a wide variety of disciplines and knowledge in the field is rapidly growing, especially as the amount of information linking genetic differences to inherited cancer predispositions continues expanding. With the increased knowledge of genetic variability and how this relates to cancer risk there is a growing demand not only to disseminate this information into clinical practice but also to enable competent debate concerning how such information is managed and what it implies for patient care.

Topics covered by the journal include but are not limited to:

  • Original research articles on any aspect of inherited predispositions to cancer.
  • Reviews of inherited cancer predispositions.
  • Application of molecular and cytogenetic analysis to clinical decision making.
  • Clinical aspects of the management of hereditary cancers.
  • Genetic counselling issues associated with cancer genetics.
  • The role of registries in improving health care of patients with an inherited predisposition to cancer.


收录体裁
Research articles
Case Reports
Commentaries
Debate articles
Letters to the Editor
Reviews
投稿指南 https://hccpjournal.biomedcentral.com/submission-guidelines
投稿模板 https://hccpjournal.biomedcentral.com/submission-guidelines/preparing-your-manuscript
参考文献格式 https://hccpjournal.biomedcentral.com/submission-guidelines/preparing-your-manuscript
编辑信息

Editors-in-Chief
Prof Jan Lubinski, Pomeranian Medical University, Poland 
Prof Rodney Scott, University of Newcastle, Australia

Associate Editors
Prof Ian Campbell, Peter MacCallum Cancer Centre, Australia 
Prof Evgeny Imyanitov, N.N. Petrov Institute of Oncology, Russian Federation 
Prof Finlay Macrae, Royal Melbourne Hospital, Australia 
Dr Gabriela Moeslein, HELIOS St. Josefs-Hospital, Germany 
Dr Bryony Thompson, Huntsman Cancer Institute, USA & University of Melbourne, Australia

Editorial Board
Dr Elizabeth Bancroft, Royal Marsden, United Kingdom 
Dr Javier Benitez, Centro Nacional de Investigaciones Oncológicas, Spain 
Prof John d Burn, Institute of Genetic Medicine, Newcastle University 
Prof Carlos Caldas, University of Cambridge, United Kingdom 
Dr Thilo Dork, Hannover Medical School, Germany 
Dr Rosalind Eeles, Institute of Cancer Research, United Kingdom 
Dr Waltraut Friedl, University Hospital Bonn, Germany 
Prof Janis Gardovskis, Riga Stradins University, Latvia 
Prof Peter Goetz, Institute of Biology and Medical Genetics, Czech Republic 
Dr David Goldgar, University of Utah, United States 
Dr Jacek Gronwald, Pomeranian Medical University, Poland 
Prof Olga Haus, Nicolaus Copernicus University, Poland 
Prof Kari Hemminki, German Cancer Research Center (DKFZ), Germany 
Prof Shirley Hodgson, St. George's Hospital Medical School, United Kingdom 
Prof Pancras Hogendoorn, Leiden University Medical Centre, Netherlands 
Prof Nicoline Hoogerbrugge, Radboud University Medical Center, Netherlands 
Dr Anna Jakubowska, Pomeranian Medical University, Poland 
Dr Maija Kohonen-Corish, Garvan Institute of Medical Research, Australia 
Dr Noralane Lindor, Mayo Clinic, United States 
Prof Dietmar Lohmann, Universitätsklinikum Essen, Germany 
Dr Henry Lynch, Creighton University School of Medicine, United States 
Prof Andres Metspalu, University of Tartu, Estonia 
Dr Pal Moller, Norwegian Radium Hospital, Norway 
Prof Steven Narod, Women's College Research Institute, Canada 
Prof Nicolás Pilar, University of Deusto,University of the Basque Country, Spain 
Prof Thangarajan Rajkumar, Cancer Institute (WIA), India 
Dr Muhamad Usman Rashid, Shaukat Khanum Memorial Cancer Hospital, Pakistan
Dr Timothy Rebbeck, University of Pennsylvania, United States 
Prof Gad Rennert, Carmel Medical Center and Faculty of Medicine, Technion, Israel 
Dr Raquel Seruca, University of Porto (IPATIMUP), Portugal 
Prof Ryszard Slomski, Institute of Human Genetics, Poland 
Prof Hagay Sobol, Paoli-Calmettes Institute, France 
Prof Allan Spigelman, St. Vincent's Clinical School, Australia 
Dr Bente Talseth-Palmer, University of Newcastle, Australia 
Prof Aad Tibben, Leiden University Medical Centre, Netherlands 
Dr Joji Utsunomiya, Hyogo College of Medicine, Japan


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug